Skip to content

Case Study: Amendment for Officer Exculpation. Shareholder Meeting Advisory, Institutional Investor Intelligence, Retail Outreach

NASDAQ Listed Small Cap Biotechnology Company

A medical specialist looking at a specimen

Assignment and Challenges

A small cap biotechnology company was facing a shareholder vote to amend its certificate of incorporation to allow for officer exculpation provisions. There were two significant obstacles to passing this vote:

  1. The vote requirement to pass the proposal was 2/3’s of the outstanding shares voting in favor. While this vote requirement is mathematically possible, from a practical standpoint this threshold is rarely achieved.
  2. Complicating matters, Glass Lewis recommended voting against these proposals, so negative votes were present at the start of the solicitation from institutions that follow Glass Lewis recommendations.

Solution

Knowing that this vote would be a challenge, Alliance Advisors brought three internal teams to the solicitation: Shareholder Meeting Advisory, Institutional Investor Intelligence and Retail Outreach.

At the onset, our Institutional Investor team began identifying all of the financial institutions, custodial relationships, and beneficial shareholders present on the Non-Objecting Beneficial Owners (NOBO) list. Using our proprietary data, Alliance Advisors was able to precisely identify the underlying investors behind each custodian.

Once the institutional investors were identified, our team began the outreach process to obtain voting instructions. Simultaneously, our Retail Outreach team began soliciting retail shareholders to facilitate telephone, text and email voting.

Both groups use a combination of our proprietary text-to-vote, email-to-vote and live telephone voting platforms. These technologies are designed to allow us to gather votes from both the institutional and retail shares, down to the smallest shareholder.

Results

Despite 7% of the outstanding shares voting against the proposal, Alliance Advisors was able to successfully deliver the required vote. A quorum of 84% of the outstanding shares was achieved with 67% of the outstanding shares voting in favor of the Officer Exculpation Amendment. By designing a campaign that focused on maximizing participation from both institutional and retail shareholders, Alliance Advisors was able to deliver an exceptionally high quorum to overcome the negative votes.

Shareholder Meeting Advisory & Retail Outreach, Institutional Investor Intelligence

NASDAQ Listed Small Cap Biotechnology Company

Alliance Advisors Logo Transparent

纽约华盛顿特区• 多伦多 温哥华
伦敦 德班 台北香港首尔

纽约

纽约州纽约市第三大道800号17层,

,邮编 10022

Get in touch

全球总部

奥弗卢克企业中心
克洛夫路 150 号 400 室
新泽西州利特尔福尔斯 07424

Get in touch

欧洲总部

42号大厦
老布罗德街25号
伦敦,EC2N 1HNSimplified Chinese (Mainland)

Get in touch

亚太地区总部

香港中环德辅道中22号
,华懋中心23楼,

Get in touch

加拿大

400 – 22 E 5th Avenue
温哥华,不列颠哥伦比亚省 V5T 1G8

Get in touch

Alliance Advisors 是一家独立咨询公司,通过我们的全球网络,专注于股东大会咨询、股东互动、薪酬、公司治理及可持续发展服务。

我们超越常规,从制定到执行以客户为先的大胆战略,最终实现成功成果。

我们的服务

联系我们